SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $7,012,000 | +45.7% | 580,000 | 0.0% | 0.06% | +30.4% |
| Q4 2014 | $4,814,000 | -4.5% | 580,000 | 0.0% | 0.05% | -13.2% |
| Q3 2014 | $5,040,000 | -20.6% | 580,000 | 0.0% | 0.05% | -29.3% |
| Q2 2014 | $6,351,000 | +22.5% | 580,000 | 0.0% | 0.08% | +17.2% |
| Q1 2014 | $5,185,000 | +18.6% | 580,000 | 0.0% | 0.06% | 0.0% |
| Q4 2013 | $4,373,000 | -6.7% | 580,000 | -9.3% | 0.06% | -23.8% |
| Q3 2013 | $4,687,000 | -70.8% | 639,400 | -74.4% | 0.08% | -75.3% |
| Q2 2013 | $16,051,000 | – | 2,496,200 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |